|国家预印本平台
首页|慢性阻塞性肺疾病患者特异性生命质量测量工具的范围综述

慢性阻塞性肺疾病患者特异性生命质量测量工具的范围综述

英文摘要

BackgroundChronic Obstructive Pulmonary DiseaseCOPDis characterized by its progressive and irreversible natureprolonged disease course and frequent exacerbations. Patients often manifest psychological issues such as anxiety and depressionwhich significantly impair their quality of life. Quality of life scales represent the most prevalent method for assessing treatment outcomes and quality of life in COPD patients. Numerous COPD-specific quality of life scales have been developed both domestically and internationally. Howeverconsiderable variations exist across different scales in terms of their dimensionsitemsand measurement levels. Consequentlycomparative analysis among these diverse scales is essential for their appropriate application. ObjectiveTo conduct a scoping review of disease-specific quality of life measurement tools for patients with chronic obstructive pulmonary disease. MethodsWe systematically searched seven databasesincluding Web of SciencePubMedEmbaseCNKIWanfang DatabaseVIP Databaseand China Biomedical Literature Databaseusing keywords related to "chronic obstructive pulmonary disease" "quality of life" and "measurement properties." The search timeline spanned from the inception of these databases to December 312023. We extracted information on the characteristics of each tool from the original development literatureand organized the dimensions addressed by these tools along with a comprehensive overview of their measurement properties. ResultsOur review encompassed 25 COPD-specific quality of life measurement toolswith 7 developed with a focus on the Chinese population and 18 originating from abroad. Notably7 of the foreign-developed scales have received extensive validation within Chinese population. Respiratory symptomsincluding shortness of breathcoughingexpectorationchest tightness and wheezingsocial interactionand the impact on daily life were found to be the most frequently measured dimensions across these scaleswith an occurrence in 92.0% of the scales. The majority of the scales utilized Cronbach's  to assess internal consistency. In terms of scale validity assessmentChinese-developed scales predominantly emphasized content and construct validitywhile foreign-developed scales validated domestically were used more frequently for criterion validity. Responsiveness/sensitivity and the minimum clinically important differenceMCIDwere relatively infrequently determined. ConclusionDespite a multitude of studies on the development and validation of COPD-specific quality of life measurement toolsthere is a discernible absence of guidance from modern measurement theories. The interest of Chinese researchers in these COPD-specific quality of life measurement tools has increased in recent years. Going forwardit is recommended to employ contemporary measurement methodologiessuch as item response theoryfor the development and validation of such scales. Additionallythe utilization of the COSMIN guidelines is advocated for a systematic assessment of the measurement properties of these scales.

王璟宁、冯俊超、李顺平、杨汀、张春瑜、姜园园、曲木诗玮、罗南、王学亮

250012 山东省济南市,山东大学齐鲁医学院公共卫生学院社会医学与卫生事业管理学系;250012 山东省济南市,山东大学卫生管理与政策研究中心 山东省重点新型智库;250012 山东省济南市,山东大学健康偏好研究中心;250012 山东省济南市,国家卫生健康委员会卫生经济与政策研究重点实验室 山东大学250012 山东省济南市,山东大学齐鲁医学院公共卫生学院社会医学与卫生事业管理学系;250012 山东省济南市,山东大学卫生管理与政策研究中心 山东省重点新型智库;250012 山东省济南市,山东大学健康偏好研究中心;250012 山东省济南市,国家卫生健康委员会卫生经济与政策研究重点实验室 山东大学250012 山东省济南市,山东大学齐鲁医学院公共卫生学院社会医学与卫生事业管理学系;250012 山东省济南市,山东大学卫生管理与政策研究中心 山东省重点新型智库;250012 山东省济南市,山东大学健康偏好研究中心;250012 山东省济南市,国家卫生健康委员会卫生经济与政策研究重点实验室 山东大学100029 北京市,国家呼吸医学中心 中国医学科学院呼吸病学研究院 国家呼吸疾病临床医学研究中心;100029 北京市,中日友好医院呼吸中心呼吸与危重症医学科100029 北京市,国家呼吸医学中心 中国医学科学院呼吸病学研究院 国家呼吸疾病临床医学研究中心;100029 北京市,中日友好医院呼吸中心呼吸与危重症医学科250000 山东省济南市,山东大学齐鲁医院呼吸与危重症医学科100029 北京市,国家呼吸医学中心 中国医学科学院呼吸病学研究院 国家呼吸疾病临床医学研究中心;100029 北京市,中日友好医院呼吸中心呼吸与危重症医学科117549 新加坡,新加坡国立大学苏瑞福公共卫生学院261042 山东省济南市,山东第二医科大学附属济南市第五人民医院呼吸内科

医学研究方法医学现状、医学发展

肺疾病,慢性阻塞性生命质量特异性测量工具量表综述

王璟宁,冯俊超,李顺平,杨汀,张春瑜,姜园园,曲木诗玮,罗南,王学亮.慢性阻塞性肺疾病患者特异性生命质量测量工具的范围综述[EB/OL].(2025-07-09)[2025-07-21].https://chinaxiv.org/abs/202507.00083.点此复制

评论